A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare LY2605541 and insulin glargine using the following
measures after participants have been treated for 26 weeks:
- Change in participants' overall blood sugar control
- The rate of night time low blood sugar episodes
- The number of participants that reach blood sugar targets without low blood sugar
episodes at night
- The rate of low blood sugar episodes reported over a 24-hour period